The role of HER2 and HER3 in HER2-amplified cancers beyond breast cancers
Abstract HER2 and HER3 play key driving functions in the pathophysiology of HER2-amplified breast cancers, but this function is less well characterized in other cancers driven by HER2 amplification. This study aimed to explore the role of HER2 and HER3 signaling in other types of HER2-amplified canc...
Enregistré dans:
Auteurs principaux: | Avisek Majumder, Manbir Sandhu, Debarko Banerji, Veronica Steri, Adam Olshen, Mark M. Moasser |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/c397830c5fdc4bd9aad3949e664aac3c |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Assessment of HER2 testing patterns, HER2+ disease, and the utilization of HER2-directed therapy in early breast cancer
par: Stenehjem DD, et autres
Publié: (2014) -
Dual HER2 blockade in the neoadjuvant and adjuvant treatment of HER2-positive breast cancer
par: Advani P, et autres
Publié: (2015) -
Robust and accurate digital measurement for HER2 amplification in HER2 equivocal breast cancer diagnosis
par: Yuefeng Wang, et autres
Publié: (2017) -
Phenotypic changes of HER2-positive breast cancer during and after dual HER2 blockade
par: Fara Brasó-Maristany, et autres
Publié: (2020) -
Mismatch repair deficiency predicts response to HER2 blockade in HER2-negative breast cancer
par: Nindo B. Punturi, et autres
Publié: (2021)